PULMATRIX, INC. Cash, Period Increase (Decrease)
PULMATRIX, INC. (PULM) reported Cash, Period Increase (Decrease) of -$5.21 million for the 12-month period ending 2015-03-31, per its 10-K filed 2015-06-10.
Discontinued › Notes
us-gaap:CashPeriodIncreaseDecrease · last filed 2015-06-10
- PULMATRIX, INC. cash, period increase (decrease) for the quarter ending 2015-03-31 was -$1.21M, a 107.80% decline year-over-year.
- PULMATRIX, INC. cash, period increase (decrease) for the quarter ending 2014-03-31 was $15.56M.
- PULMATRIX, INC. cash, period increase (decrease) for fiscal 2015 was -$5.21M, a 133.69% decline from fiscal 2014.
- PULMATRIX, INC. cash, period increase (decrease) for fiscal 2014 was $15.47M.
| Period end | Cash, Period Increase (Decrease) 3 month | Cash, Period Increase (Decrease) 9 month | Cash, Period Increase (Decrease) 12 month |
|---|---|---|---|
| 2015-03-31 | -$1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-10 | -$5.21M 10-K · filed 2015-06-10 | |
| 2014-12-31 | -$4.00M 10-Q · filed 2015-02-13 | ||
| 2014-03-31 | $15.56M derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-10 | $15.47M 10-K · filed 2015-06-10 | |
| 2013-12-31 | -$86.00K 10-Q · filed 2015-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |